<bill session="113" type="h" number="5854" updated="2015-09-01T10:21:07-04:00">
  <state datetime="2014-12-11">REFERRED</state>
  <status>
    <introduced datetime="2014-12-11"/>
  </status>
  <introduced datetime="2014-12-11"/>
  <titles>
    <title type="official" as="introduced">To allow the importation, distribution, and sale of investigational drugs and devices intended for use by terminally ill patients who execute an informed consent document.</title>
  </titles>
  <sponsor id="412276"/>
  <cosponsors/>
  <actions>
    <action datetime="2014-12-11" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill relation="unknown" session="113" type="h" number="4475"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug therapy"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Long-term, rehabilitative, and terminal care"/>
    <term name="Prescription drugs"/>
    <term name="Retail and wholesale trades"/>
    <term name="Trade restrictions"/>
  </subjects>
  <amendments/>
  <summary>12/11/2014--Introduced.
Amends the Federal Food, Drug, and Cosmetic Act to declare that nothing in it or in the Public Health Service Act shall prevent or restrict, and the Food and Drug Administration (FDA) shall not implement or enforce any law to prevent or restrict, the importation, distribution, or sale of investigational drugs or devices for terminally ill patients.</summary>
</bill>
